Clinical Trial Update: Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of Mibavademab for generalized lipodystrophy, currently recruiting in adult and pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Lipodystrophy

Drugs mentioned

• Mibavademab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Generalized Lipodystrophy | Phase 3 | Status: RECRUITING